Asymchem
About Asymchem
Certifications
Categories
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:3
-
Employees:5000+
Company types
Primary activities
Meet us at
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026
Products from Asymchem (4)
-
Product APIs & Intermediates
We leverage our experience in everything – from R&D to process innovation to navigating the complex global regulatory arena – to help clients efficiently develop and manufacture quality products • Small Molecules
• Carbapenems
• Glycans
• Peptides qq... -
Product Oligonucleotides
Asymchem’s oligonucleotide technology platform provides clients with full services in drug substance, from process development through GMP manufacturing, and drug product, from preformulation development through fill-finish. The process chemistry, analytical, formulation, and regulations teams collaborate ... -
Product Pre-Formulation / Formulation
Asymchem understands that early phase work focuses on learning as much as possible about a drug compound. Our experience across numerous chemical classes and multiple dosage forms, and our ability to develop analytical methods to assess chemical identity, purity, compatibility, and stability, makes us a na... -
Product Regulatory services
Asymchem Laboratories (Tianjin) Co., Ltd offers wide range of manufacturing services which includes regulatory services. They generate the complete cmc data package for regulatory filings including: API synthesis flow chart, process control, raw material acceptance criteria and API specifications , API bat...
Asymchem Resources (2)
-
Brochure Service Overview
Driven by curiosity and the desire to break new ground, leading scientists and technologists are attracted to Asymchem’s culture of innovation. It’s a culture built on operational agility and flexibility, a willingness to invest and share risks, and demonstrated expertise in strategic collaboration and partnership.
Working from this forward-leaning posture, Asymchem successfully supports products at every stage of the lifecycle from preclinical to large-scale manufacturing, with custom development services ranging from investigational new drug (IND) support to Phase III clinical trials and technology transfers for commercial supply.
